Find clinical trials for Lymphoma in Aurora, CO
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Aurora, CO, USA:
of MT-601 administration to patients with Relapsed or Refractory Lymphoma. The starting dose administered is 200 x 10\^6 cells (flat dosing)....
Phase 1
Aurora, Colorado, United States and 6 other locations
chimeric antigen receptor (CAR) targeting cluster of differentiation (CD)19 and CD20 in participants with aggressive large B-cell lymphoma....
Phase 1, Phase 2
Denver, Colorado, United States and 25 other locations
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Denver, Colorado, United States and 71 other locations
This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL)....
Phase 1
Aurora, Colorado, United States and 9 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Boulder, Colorado, United States and 71 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Denver, Colorado, United States and 214 other locations
This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...
Phase 2
Aurora, Colorado, United States and 59 other locations
by the intravenous (IV) route to participants with solid tumors or lymphomas.The main goals of this study are to:* Find the recommended dose...
Phase 1, Phase 2
Denver, Colorado, United States and 8 other locations
This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...
Phase 2
Aurora, Colorado, United States and 48 other locations
The purpose of this trial is to measure the following in participants with relapsed and/or refractory B-cell lymphoma who receive epcoritama...
Phase 1, Phase 2
Denver, Colorado, United States and 84 other locations
Clinical trials
Research sites
Resources
Legal